Selective Laser Trabeculoplasty versus Brimonidine Tartrate 0.2%/Timolol Maleate 0.5% as Adjunct Therapy in Primary Open Angle Glaucoma: A Randomized Prospective Pilot Study

Abstract

Selective laser trabeculoplasty and brimonidine tartrate 0.2%/timolol maleate 0.5% were shown to be equivalent in lowering intraocular pressure in uncontrolled primary open angle glaucoma patients when used as adjunct therapy for patients on a prostaglandin analog. Additionally, this is the first prospective study of optometrists performing selective laser trabeculoplasty. Although this study had a small sample size, the results appeared to show that efficacy and complication rates were comparable to previously published data; however, these results need to be confirmed with a larger multi-centered trial